N-Nitroso Enzalutamide Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142179 |
| CAS No | NA |
| Mol.F. | C14H14N2O4 |
| Mol.Wt. | 274.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142180 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142181 |
| CAS No | NA |
| Mol.F. | C14H14N2O3 |
| Mol.Wt. | 258.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142182 |
| CAS No | NA |
| Mol.F. | C15H20N2O3 |
| Mol.Wt. | 276.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142184 |
| CAS No | NA |
| Mol.F. | C17H14BrClFN5O4 |
| Mol.Wt. | 486.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142183 |
| CAS No | 51715-17-4 |
| Mol.F. | C16H13ClN4O2 |
| Mol.Wt. | 328.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142185 |
| CAS No | NA |
| Mol.F. | C15H9BrClFN4O3 |
| Mol.Wt. | 427.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142186 |
| CAS No | NA |
| Mol.F. | C21H22BrClFN5O4 |
| Mol.Wt. | 542.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142187 |
| CAS No | NA |
| Mol.F. | C17H14Cl2FN5O4 |
| Mol.Wt. | 442.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142188 |
| CAS No | NA |
| Mol.F. | C16H12BrClFN5O4 |
| Mol.Wt. | 472.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142189 |
| CAS No | NA |
| Mol.F. | C17H19N3OS |
| Mol.Wt. | 313.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142190 |
| CAS No | NA |
| Mol.F. | C12H8N2OS |
| Mol.Wt. | 228.27g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142191 |
| CAS No | NA |
| Mol.F. | C17H19N3O2S |
| Mol.Wt. | 329.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142192 |
| CAS No | NA |
| Mol.F. | C29H26N4OS2 |
| Mol.Wt. | 510.67 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142193 |
| CAS No | NA |
| Mol.F. | C56H77N17O13 |
| Mol.Wt. | 1196.34 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142194 |
| CAS No | NA |
| Mol.F. | C10H12N4OS |
| Mol.Wt. | 236.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |